CL Colgate Palmolive Co

                                      UNITED STATES 
                           SECURITIES AND EXCHANGE COMMISSION 
                                  WASHINGTON, DC 20549 
                                    ________________ 
 
                                        FORM 8-K 
 
                                     CURRENT REPORT 
                        Pursuant to Section 13 or 15(d) of the 
                          Securities Exchange Act of 1934 
 
Date of Report (Date of earliest event reported) September 20, 2019 (September 19, 2019) 
                               COLGATE PALMOLIVE COMPANY 
                  (Exact name of registrant as specified in its charter) 
 
     Delaware                             1-644                       13-1815595 
(State or Other Jurisdiction           (Commission                  (IRS Employer 
 of Incorporation)                      File Number)                 Identification No.) 
 
 
     300 Park Avenue, New York, New York                             10022 
  (Address of Principal Executive Offices)                         (Zip Code) 
 
          Registrant's telephone number, including area code (212) 310-2000 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
Securities registered pursuant to Section 12(b) of the Act: 
 
Title of each class              Trading Symbol(s)        Name of each exchange on which 
                                                                    registered 
Common Stock, $1.00 par value          CL                 New York Stock Exchange 
0.500% Notes due 2026                 CL 26               New York Stock Exchange 
1.375% Notes due 2034                 CL 34               New York Stock Exchange 
 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On September 19, 2019, Colgate-Palmolive Company ("Colgate") completed its previously announced acquisition of Laboratoires Filorga Cosmétiques, pursuant to a Share Purchase Agreement, dated as of July 11, 2019, by and between Colgate and Filorga Initiatives, for a cash purchase price of approximately €1,516 million (approximately US$ 1,674 million), which includes interest on the previously disclosed equity purchase price.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

COLGATE-PALMOLIVE COMPANY

By: /s/ Jennifer M. Daniels

Name: Jennifer M. Daniels

Title: Chief Legal Officer and Secretary

Date: September 20, 2019

(END) Dow Jones Newswires

September 20, 2019 17:32 ET (21:32 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.